VISTA Eye Specialists Opens its 13th Outlet in Johor Bahru with Overwhelming Success
PETALING JAYA, Malaysia, Dec. 16, 2022 /PRNewswire/ -- VISTA Eye Specialist (VISTA) opened its 2nd outlet in Johor Bahru (JB) in November with dazzling success, bringing its total outlets in Malaysia to 13, and embarking on its journey to make available world-class eye specialist care to more Johorians. Located at the western side of Malaysia's most southern city and bordering...
EmeTerm Enters Walmart and Best Buy with New Technology
VANCOUVER, BC, Dec. 16, 2022 /PRNewswire/ -- EmeTerm, the anti-nausea wristband developed by WAT Medical Enterprise, Ltd., received its FDA clearance in 2018 as a medical device that manages nausea-induced vomiting. In December 2022, EmeTerm expanded into the retail market by introducing their new product - EmeTerm Explore in Walmart and Best Buy Canada. With outdoor activities becoming more common than ever since the COVID-19 pandemic,...
Bioved Pharmaceuticals, Inc. announces the results of its Phase III Randomized Clinical Trial in Moderate Covid-19 with Artovid-20®, a natural plant-based oral product
SAN JOSE, Calif., Dec. 16, 2022 /PRNewswire/ -- Published Nov 25, 2022 in the highly respected peer-reviewed journal Phytotherapy Research, results show statistically significant reduction in duration of illness and severity scores of the symptoms associated with Covid-19. In addition, statistical significance was seen in alleviation of symptoms such as taste and smell from Day 5. Most importantly,...
Novavax Announces Proposed Offering of $125 Million of Convertible Senior Notes
GAITHERSBURG, Md., Dec. 15, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced a proposed offering of $125 million aggregate principal amount of convertible senior notes due 2027 (the "notes"). The notes will be offered and sold...
Siemens Earns the Frost & Sullivan 2022 Company of the Year Award for Its Pioneering Approach in the Data Center Industry
Siemens delivers a cost-effective and scalable ecosystem that significantly improves data center operators' performance. SAN ANTONIO, Dec. 15, 2022 /PRNewswire/ -- Based on its recent analysis of the workforce engagement and intelligent automation industry, Frost & Sullivan recognizes Siemens with the 2022 Company of the Year Award for its innovative and leading approach in the...
Lunit AI Can Help Tuberculosis Screening in Prisons, as Published in The Lancet Regional Health – Americas
Recent study suggests that AI-based x-ray interpretation algorithms may be an efficient means to improve TB case detection among incarcerated populations Lunit INSIGHT CXR showed the most superior performance among the tested cohort, with greater accuracy and generalizability among subgroups SEOUL, South Korea, Dec. 15, 2022 /PRNewswire/ -- Findings from a...
China Pharma Holdings, Inc. Announced that several products are included in the Catalogue of Medicines for People Infected with COVID-19
HAIKOU, China, Dec. 15, 2022 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that its drugs were listed in The Catalogue of Medicines for People Infected with COVID-19 (First Edition) (hereinafter referred to as the Catalogue) published...
BIORCHESTRA receives Citation from the Korean Minister of Trade, Industry, and Energy
A leader in creating jobs through the advancement of RNA-based therapeutics A contributor to a high employment rate in Korea's healthcare industry BOSTON, Dec. 15, 2022 /PRNewswire/ -- BIORCHESTRA ("BIORCHESTRA" or the "Company"), a RNA therapeutics company with offices in Daejeon, South Korea, and Cambridge, Massachusetts, USA and focused on neurodegenerative and rare...
Duality announced the appointment of Dr. Pasi A. Jänne as Member of SAB
PRINCETON, N. J., SHANGHAI and SUZHOU, China, Dec. 15, 2022 /PRNewswire/ -- Duality Biotherapeutics, Inc. ("Duality" or "the Company") today announced the appointment of Dr. Pasi A. Jänne as member of SAB. Dr. Jänne will provide strategic advice and guidance for the Company's clinical and translation medicine strategy development to elevate the Company's innovation in the field of Antibody Drug...
Nevisense for skin barrier evaluation included in large Australian birth cohort study
STOCKHOLM, Dec. 15, 2022 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announced today that SciBase has received an order for skin barrier assessment products to be included in one of the world's largest cohort studies - The ORIGINS Project, which is a collaboration between Joondalup Health Campus and Telethon Kids...
